The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fibromyalgia Treatment Market Research Report 2025
Synopsis
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
The global Fibromyalgia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Treatment.
Report Scope
The Fibromyalgia Treatment market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fibromyalgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fibromyalgia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Segment by Type
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Segment by Application
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fibromyalgia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fibromyalgia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
The global Fibromyalgia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Treatment.
Report Scope
The Fibromyalgia Treatment market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fibromyalgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fibromyalgia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Segment by Type
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Segment by Application
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fibromyalgia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fibromyalgia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fibromyalgia Treatment Market Overview
1.1 Product Overview and Scope of Fibromyalgia Treatment
1.2 Fibromyalgia Treatment Segment by Type
1.2.1 Global Fibromyalgia Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Fibromyalgia Treatment Segment by Application
1.3.1 Global Fibromyalgia Treatment Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Global Fibromyalgia Treatment Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Treatment Revenue 2019-2030
1.4.2 Global Fibromyalgia Treatment Sales 2019-2030
1.4.3 Global Fibromyalgia Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fibromyalgia Treatment Market Competition by Manufacturers
2.1 Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fibromyalgia Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fibromyalgia Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Fibromyalgia Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fibromyalgia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fibromyalgia Treatment, Product Type & Application
2.7 Fibromyalgia Treatment Market Competitive Situation and Trends
2.7.1 Fibromyalgia Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fibromyalgia Treatment Players Market Share by Revenue
2.7.3 Global Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fibromyalgia Treatment Retrospective Market Scenario by Region
3.1 Global Fibromyalgia Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fibromyalgia Treatment Global Fibromyalgia Treatment Sales by Region: 2019-2030
3.2.1 Global Fibromyalgia Treatment Sales by Region: 2019-2024
3.2.2 Global Fibromyalgia Treatment Sales by Region: 2025-2030
3.3 Global Fibromyalgia Treatment Global Fibromyalgia Treatment Revenue by Region: 2019-2030
3.3.1 Global Fibromyalgia Treatment Revenue by Region: 2019-2024
3.3.2 Global Fibromyalgia Treatment Revenue by Region: 2025-2030
3.4 North America Fibromyalgia Treatment Market Facts & Figures by Country
3.4.1 North America Fibromyalgia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fibromyalgia Treatment Sales by Country (2019-2030)
3.4.3 North America Fibromyalgia Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fibromyalgia Treatment Market Facts & Figures by Country
3.5.1 Europe Fibromyalgia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fibromyalgia Treatment Sales by Country (2019-2030)
3.5.3 Europe Fibromyalgia Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fibromyalgia Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Fibromyalgia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fibromyalgia Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Fibromyalgia Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fibromyalgia Treatment Market Facts & Figures by Country
3.7.1 Latin America Fibromyalgia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fibromyalgia Treatment Sales by Country (2019-2030)
3.7.3 Latin America Fibromyalgia Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fibromyalgia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Fibromyalgia Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fibromyalgia Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fibromyalgia Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fibromyalgia Treatment Sales by Type (2019-2030)
4.1.1 Global Fibromyalgia Treatment Sales by Type (2019-2024)
4.1.2 Global Fibromyalgia Treatment Sales by Type (2025-2030)
4.1.3 Global Fibromyalgia Treatment Sales Market Share by Type (2019-2030)
4.2 Global Fibromyalgia Treatment Revenue by Type (2019-2030)
4.2.1 Global Fibromyalgia Treatment Revenue by Type (2019-2024)
4.2.2 Global Fibromyalgia Treatment Revenue by Type (2025-2030)
4.2.3 Global Fibromyalgia Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Fibromyalgia Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fibromyalgia Treatment Sales by Application (2019-2030)
5.1.1 Global Fibromyalgia Treatment Sales by Application (2019-2024)
5.1.2 Global Fibromyalgia Treatment Sales by Application (2025-2030)
5.1.3 Global Fibromyalgia Treatment Sales Market Share by Application (2019-2030)
5.2 Global Fibromyalgia Treatment Revenue by Application (2019-2030)
5.2.1 Global Fibromyalgia Treatment Revenue by Application (2019-2024)
5.2.2 Global Fibromyalgia Treatment Revenue by Application (2025-2030)
5.2.3 Global Fibromyalgia Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Fibromyalgia Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Fibromyalgia Treatment Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Fibromyalgia Treatment Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Fibromyalgia Treatment Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Fibromyalgia Treatment Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Aptinyx
6.5.1 Aptinyx Corporation Information
6.5.2 Aptinyx Description and Business Overview
6.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aptinyx Fibromyalgia Treatment Product Portfolio
6.5.5 Aptinyx Recent Developments/Updates
6.6 Prismic Pharmaceuticals
6.6.1 Prismic Pharmaceuticals Corporation Information
6.6.2 Prismic Pharmaceuticals Description and Business Overview
6.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.6.5 Prismic Pharmaceuticals Recent Developments/Updates
6.7 Innovative Med Concepts
6.6.1 Innovative Med Concepts Corporation Information
6.6.2 Innovative Med Concepts Description and Business Overview
6.6.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Innovative Med Concepts Fibromyalgia Treatment Product Portfolio
6.7.5 Innovative Med Concepts Recent Developments/Updates
6.8 Intec Pharma Ltd.
6.8.1 Intec Pharma Ltd. Corporation Information
6.8.2 Intec Pharma Ltd. Description and Business Overview
6.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Product Portfolio
6.8.5 Intec Pharma Ltd. Recent Developments/Updates
6.9 Astellas Pharma
6.9.1 Astellas Pharma Corporation Information
6.9.2 Astellas Pharma Description and Business Overview
6.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Astellas Pharma Fibromyalgia Treatment Product Portfolio
6.9.5 Astellas Pharma Recent Developments/Updates
6.10 Savella
6.10.1 Savella Corporation Information
6.10.2 Savella Description and Business Overview
6.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Savella Fibromyalgia Treatment Product Portfolio
6.10.5 Savella Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 Mylan NV
6.12.1 Mylan NV Corporation Information
6.12.2 Mylan NV Fibromyalgia Treatment Description and Business Overview
6.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mylan NV Fibromyalgia Treatment Product Portfolio
6.12.5 Mylan NV Recent Developments/Updates
6.13 Teva Pharmaceutical Industries
6.13.1 Teva Pharmaceutical Industries Corporation Information
6.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Description and Business Overview
6.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Product Portfolio
6.13.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.14 Daiichi Sankyo
6.14.1 Daiichi Sankyo Corporation Information
6.14.2 Daiichi Sankyo Fibromyalgia Treatment Description and Business Overview
6.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Daiichi Sankyo Fibromyalgia Treatment Product Portfolio
6.14.5 Daiichi Sankyo Recent Developments/Updates
6.15 Forest Pharmaceuticals
6.15.1 Forest Pharmaceuticals Corporation Information
6.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Description and Business Overview
6.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.15.5 Forest Pharmaceuticals Recent Developments/Updates
6.16 Meiji Seika Pharma
6.16.1 Meiji Seika Pharma Corporation Information
6.16.2 Meiji Seika Pharma Fibromyalgia Treatment Description and Business Overview
6.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Meiji Seika Pharma Fibromyalgia Treatment Product Portfolio
6.16.5 Meiji Seika Pharma Recent Developments/Updates
6.17 Tonix Pharmaceuticals
6.17.1 Tonix Pharmaceuticals Corporation Information
6.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Description and Business Overview
6.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.17.5 Tonix Pharmaceuticals Recent Developments/Updates
6.18 Theravance Biopharma
6.18.1 Theravance Biopharma Corporation Information
6.18.2 Theravance Biopharma Fibromyalgia Treatment Description and Business Overview
6.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Theravance Biopharma Fibromyalgia Treatment Product Portfolio
6.18.5 Theravance Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fibromyalgia Treatment Industry Chain Analysis
7.2 Fibromyalgia Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fibromyalgia Treatment Production Mode & Process
7.4 Fibromyalgia Treatment Sales and Marketing
7.4.1 Fibromyalgia Treatment Sales Channels
7.4.2 Fibromyalgia Treatment Distributors
7.5 Fibromyalgia Treatment Customers
8 Fibromyalgia Treatment Market Dynamics
8.1 Fibromyalgia Treatment Industry Trends
8.2 Fibromyalgia Treatment Market Drivers
8.3 Fibromyalgia Treatment Market Challenges
8.4 Fibromyalgia Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Fibromyalgia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Fibromyalgia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Fibromyalgia Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Fibromyalgia Treatment Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Fibromyalgia Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Fibromyalgia Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Fibromyalgia Treatment Average Price (USD/KG) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Fibromyalgia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Fibromyalgia Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fibromyalgia Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Fibromyalgia Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fibromyalgia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Fibromyalgia Treatment Sales by Region (2019-2024) & (KG)
Table 18. Global Fibromyalgia Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Fibromyalgia Treatment Sales by Region (2025-2030) & (KG)
Table 20. Global Fibromyalgia Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Fibromyalgia Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Fibromyalgia Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Fibromyalgia Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Fibromyalgia Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Fibromyalgia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Fibromyalgia Treatment Sales by Country (2019-2024) & (KG)
Table 27. North America Fibromyalgia Treatment Sales by Country (2025-2030) & (KG)
Table 28. North America Fibromyalgia Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Fibromyalgia Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Fibromyalgia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Fibromyalgia Treatment Sales by Country (2019-2024) & (KG)
Table 32. Europe Fibromyalgia Treatment Sales by Country (2025-2030) & (KG)
Table 33. Europe Fibromyalgia Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Fibromyalgia Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Fibromyalgia Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Fibromyalgia Treatment Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Fibromyalgia Treatment Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Fibromyalgia Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Fibromyalgia Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fibromyalgia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Fibromyalgia Treatment Sales by Country (2019-2024) & (KG)
Table 42. Latin America Fibromyalgia Treatment Sales by Country (2025-2030) & (KG)
Table 43. Latin America Fibromyalgia Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fibromyalgia Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Fibromyalgia Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Fibromyalgia Treatment Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Fibromyalgia Treatment Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Fibromyalgia Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Fibromyalgia Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Fibromyalgia Treatment Sales (KG) by Type (2019-2024)
Table 51. Global Fibromyalgia Treatment Sales (KG) by Type (2025-2030)
Table 52. Global Fibromyalgia Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Fibromyalgia Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Fibromyalgia Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Fibromyalgia Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Fibromyalgia Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Fibromyalgia Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Fibromyalgia Treatment Price (USD/KG) by Type (2019-2024)
Table 59. Global Fibromyalgia Treatment Price (USD/KG) by Type (2025-2030)
Table 60. Global Fibromyalgia Treatment Sales (KG) by Application (2019-2024)
Table 61. Global Fibromyalgia Treatment Sales (KG) by Application (2025-2030)
Table 62. Global Fibromyalgia Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Fibromyalgia Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Fibromyalgia Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Fibromyalgia Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Fibromyalgia Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Fibromyalgia Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Fibromyalgia Treatment Price (USD/KG) by Application (2019-2024)
Table 69. Global Fibromyalgia Treatment Price (USD/KG) by Application (2025-2030)
Table 70. Eli Lilly and Company Corporation Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 73. Eli Lilly and Company Fibromyalgia Treatment Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 78. Pfizer Fibromyalgia Treatment Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 83. Novartis AG Fibromyalgia Treatment Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 88. Allergan Fibromyalgia Treatment Product
Table 89. Allergan Recent Developments/Updates
Table 90. Aptinyx Corporation Information
Table 91. Aptinyx Description and Business Overview
Table 92. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 93. Aptinyx Fibromyalgia Treatment Product
Table 94. Aptinyx Recent Developments/Updates
Table 95. Prismic Pharmaceuticals Corporation Information
Table 96. Prismic Pharmaceuticals Description and Business Overview
Table 97. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 98. Prismic Pharmaceuticals Fibromyalgia Treatment Product
Table 99. Prismic Pharmaceuticals Recent Developments/Updates
Table 100. Innovative Med Concepts Corporation Information
Table 101. Innovative Med Concepts Description and Business Overview
Table 102. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 103. Innovative Med Concepts Fibromyalgia Treatment Product
Table 104. Innovative Med Concepts Recent Developments/Updates
Table 105. Intec Pharma Ltd. Corporation Information
Table 106. Intec Pharma Ltd. Description and Business Overview
Table 107. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 108. Intec Pharma Ltd. Fibromyalgia Treatment Product
Table 109. Intec Pharma Ltd. Recent Developments/Updates
Table 110. Astellas Pharma Corporation Information
Table 111. Astellas Pharma Description and Business Overview
Table 112. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 113. Astellas Pharma Fibromyalgia Treatment Product
Table 114. Astellas Pharma Recent Developments/Updates
Table 115. Savella Corporation Information
Table 116. Savella Description and Business Overview
Table 117. Savella Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 118. Savella Fibromyalgia Treatment Product
Table 119. Savella Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Corporation Information
Table 121. Sun Pharmaceutical Industries Description and Business Overview
Table 122. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 123. Sun Pharmaceutical Industries Fibromyalgia Treatment Product
Table 124. Sun Pharmaceutical Industries Recent Developments/Updates
Table 125. Mylan NV Corporation Information
Table 126. Mylan NV Description and Business Overview
Table 127. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 128. Mylan NV Fibromyalgia Treatment Product
Table 129. Mylan NV Recent Developments/Updates
Table 130. Teva Pharmaceutical Industries Corporation Information
Table 131. Teva Pharmaceutical Industries Description and Business Overview
Table 132. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 133. Teva Pharmaceutical Industries Fibromyalgia Treatment Product
Table 134. Teva Pharmaceutical Industries Recent Developments/Updates
Table 135. Daiichi Sankyo Corporation Information
Table 136. Daiichi Sankyo Description and Business Overview
Table 137. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 138. Daiichi Sankyo Fibromyalgia Treatment Product
Table 139. Daiichi Sankyo Recent Developments/Updates
Table 140. Forest Pharmaceuticals Corporation Information
Table 141. Forest Pharmaceuticals Description and Business Overview
Table 142. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 143. Forest Pharmaceuticals Fibromyalgia Treatment Product
Table 144. Forest Pharmaceuticals Recent Developments/Updates
Table 145. Meiji Seika Pharma Corporation Information
Table 146. Meiji Seika Pharma Description and Business Overview
Table 147. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 148. Meiji Seika Pharma Fibromyalgia Treatment Product
Table 149. Meiji Seika Pharma Recent Developments/Updates
Table 150. Tonix Pharmaceuticals Corporation Information
Table 151. Tonix Pharmaceuticals Description and Business Overview
Table 152. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 153. Tonix Pharmaceuticals Fibromyalgia Treatment Product
Table 154. Tonix Pharmaceuticals Recent Developments/Updates
Table 155. Theravance Biopharma Corporation Information
Table 156. Theravance Biopharma Description and Business Overview
Table 157. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)
Table 158. Theravance Biopharma Fibromyalgia Treatment Product
Table 159. Theravance Biopharma Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Fibromyalgia Treatment Distributors List
Table 163. Fibromyalgia Treatment Customers List
Table 164. Fibromyalgia Treatment Market Trends
Table 165. Fibromyalgia Treatment Market Drivers
Table 166. Fibromyalgia Treatment Market Challenges
Table 167. Fibromyalgia Treatment Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fibromyalgia Treatment
Figure 2. Global Fibromyalgia Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Fibromyalgia Treatment Market Share by Type in 2023 & 2030
Figure 4. Antidepressants Product Picture
Figure 5. Anticonvulsants Product Picture
Figure 6. Muscle Relaxants Product Picture
Figure 7. Narcotic Analgesics Product Picture
Figure 8. Non-narcotic Analgesics Product Picture
Figure 9. Global Fibromyalgia Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Fibromyalgia Treatment Market Share by Application in 2023 & 2030
Figure 11. Hospitals Pharmacies
Figure 12. Clinic Pharmacy
Figure 13. Retail Drug Stores
Figure 14. Online Pharmacies
Figure 15. Global Fibromyalgia Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Fibromyalgia Treatment Market Size (2019-2030) & (US$ Million)
Figure 17. Global Fibromyalgia Treatment Sales (2019-2030) & (KG)
Figure 18. Global Fibromyalgia Treatment Average Price (USD/KG) & (2019-2030)
Figure 19. Fibromyalgia Treatment Report Years Considered
Figure 20. Fibromyalgia Treatment Sales Share by Manufacturers in 2023
Figure 21. Global Fibromyalgia Treatment Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Fibromyalgia Treatment Players: Market Share by Revenue in 2023
Figure 23. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Fibromyalgia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Fibromyalgia Treatment Sales Market Share by Country (2019-2030)
Figure 26. North America Fibromyalgia Treatment Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Fibromyalgia Treatment Sales Market Share by Country (2019-2030)
Figure 30. Europe Fibromyalgia Treatment Revenue Market Share by Country (2019-2030)
Figure 31. Germany Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region (2019-2030)
Figure 38. China Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Fibromyalgia Treatment Sales Market Share by Country (2019-2030)
Figure 49. Latin America Fibromyalgia Treatment Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Fibromyalgia Treatment Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Fibromyalgia Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Fibromyalgia Treatment by Type (2019-2030)
Figure 59. Global Revenue Market Share of Fibromyalgia Treatment by Type (2019-2030)
Figure 60. Global Fibromyalgia Treatment Price (USD/KG) by Type (2019-2030)
Figure 61. Global Sales Market Share of Fibromyalgia Treatment by Application (2019-2030)
Figure 62. Global Revenue Market Share of Fibromyalgia Treatment by Application (2019-2030)
Figure 63. Global Fibromyalgia Treatment Price (USD/KG) by Application (2019-2030)
Figure 64. Fibromyalgia Treatment Value Chain
Figure 65. Fibromyalgia Treatment Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
